CML patients with more comorbidities at diagnosis have significantly reduced overall survival, according to an analysis of the randomized CML-Study IV. Chronic myeloid leukemia (CML) patients with ...
Patients with CML who have higher proportions of natural killer immune cells, and more mature natural killer cells, fare better when discontinuing therapy with imatinib. Patients with chronic myeloid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results